Discovery Marketplace
Novel bioactive compound candidates identified by AI from 9,238 substances and 1.12M PubMed studies. Each discovery is cryptographically sealed as prior art.
Sealed Discoveries
Single compounds with X-Vault proof-of-discovery. PDF report + Merkle hash.
Full discovery report + PDF + X-Vault seal. BiohacksAI retains 90% IP. You receive 10% royalty if patent arises.
Full commercial and patent rights. BiohacksAI retains 10% royalty on any IP commercialisation. One buyer only.
PALMOSTATIN B
L1CAM interactions
PNU74654
Adaptive Immune System
M084
Stimuli-sensing channels
UROLITHIN D
Membrane Trafficking
MIDOSTAURIN
Hemostasis
AST 487
Hemostasis
NINTEDANIB
Neuronal System
SU 014813
Signaling by ERBB2
R 406
Hemostasis
KW 2449
Hemostasis
FEDRATINIB
Hemostasis
TAE 684
Hemostasis
MOLIBRESIB
Cell Cycle
LESTAURTINIB
Hemostasis
Compound Families
Groups of understudied compounds with high target-profile similarity (Jaccard ≥ 0.5). Each family shares functional biology — potential novel series.
BRD4 / APP / PTGS2 family
BRD4 family - Sensory Perception
Computational hypothesis · not a clinical claim
TNF / ACHE family
TNF family - Potassium Channels
Computational hypothesis · not a clinical claim
TNF / BRD4 / IL1B family
TNF family - Innate Immune System
Computational hypothesis · not a clinical claim
SLC2A4 family
SLC2A4 family - Integration of energy metabolism
Computational hypothesis · not a clinical claim
SIRT3 / SIRT1 / ABL1 family
SIRT3 family - Downstream signaling events of B Cell Receptor (BCR)
Computational hypothesis · not a clinical claim
Target-Convergence Clusters
Multiple understudied compounds converging on the same high-value molecular target. Each cluster is a potential multi-compound hypothesis.
All discoveries are hypothesis candidates based on computational analysis of PubMed data and molecular target graphs — not confirmed mechanisms. X-Vault seals provide cryptographic proof of discovery timestamp and corpus version. Clusters and families are previews only; sealing available on request. Patent: EVE-PAT-2026-001 · Organiq Sweden AB